Barclays PLC (BCS)

CORAL GABLES, Fla., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult-to-treat diseases, today announced that Rich Daly, President and CEO of Catalyst, along with other members of Catalyst's management team, will participate in the upcoming Barclays 28th Annual Global Healthcare Conference on Tuesday, March 10, 2026, being held in Miami, Florida.

Barclays analysts on Tuesday slashed their peak sales forecasts for Novo Nordisk's next-generation obesity drug CagriSema to just $2 billion from $12 billion following disappointing trial results for the drug a day earlier.

FRANKLIN LAKES, N.J., Feb. 23, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Barclays 28th Annual Global Healthcare Conference on Tuesday, March 10, 2026 at 8:30 am Eastern Time.

The Zacks Foreign Bank stocks like HSBC, ITUB and BCS are expected to gain from restructuring efforts and lower interest rates.

AMG National Trust Bank trimmed its holdings in shares of Barclays PLC (NYSE: BCS) by 25.0% in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 79,286 shares of the financial services provider's stock after selling 26,421 shares during the period.

Assetmark Inc. raised its holdings in shares of Barclays PLC (NYSE: BCS) by 72.8% in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 81,979 shares of the financial services provider's stock after acquiring an additional 34,543 shares during the quarter. Assetmark Inc.'s

Voyager Technologies, Inc. (VOYG) Presents at Barclays 43rd Annual Industrial Select Conference Transcript

UBS reiterated its 'buy' rating on Barclays PLC (LSE:BARC) and raised its 12-month price target to 580p from 570p following fourth quarter results. The shares were trading at 477p (down 1.4%),  implying 23% capital upside to the Swiss bank's revised target.

IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences Corporation (NYSE: EW) today announced its chief financial officer, Scott Ullem, is scheduled to present at two upcoming conferences: Tuesday, March 10, 2026 at 10:00 a.m. ET at the Barclays 28th Annual Global Healthcare Conference Wednesday, March 11, 2026 at 10:00 a.m. ET at the Leerink Global Healthcare Conference A live webcast of each presentation will be available on the Edwards investor relations website at http://ir.edwards.com/, wit.

Ralliant Corporation (RAL) Presents at Barclays 43rd Annual Industrial Select Conference Transcript

Barclays PLC shares rose 2.75% to 487p on Wednesday, benefiting from the support of analysts at two rival banks, with both feeling the lender is in better shape than its valuation suggests, with improving returns and scope for higher payouts. Deutsche Bank's Robert Noble sees the blue eagle bank progressively improving to 2028 "and we doubt the story stops there", forecasting rising return on tangible equity each year and calling it his preferred large-cap UK bank.

Here is how Barclays (BCS) and Bank First Corporation (BFC) have performed compared to their sector so far this year.

NORTHFIELD, Ill., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline”) (Nasdaq: MDLN) today announced that Jim Boyle, Chief Executive Officer, and Mike Drazin, Chief Financial Officer, are scheduled to present at the Barclays 28th Annual Global Healthcare Conference in Miami Beach, FL, on Wednesday, March 11, 2026, at 9:30am ET.

Investors interested in stocks from the Banks - Foreign sector have probably already heard of Barclays (BCS) and Banco Itau (ITUB). But which of these two stocks is more attractive to value investors?

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.